New York State Teachers Retirement System Lowers Stock Position in Amedisys, Inc. (NASDAQ:AMED)

New York State Teachers Retirement System cut its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 4.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 38,776 shares of the health services provider’s stock after selling 1,723 shares during the period. New York State Teachers Retirement System’s holdings in Amedisys were worth $3,686,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in AMED. Raymond James & Associates boosted its holdings in Amedisys by 6.5% during the first quarter. Raymond James & Associates now owns 11,101 shares of the health services provider’s stock worth $1,913,000 after buying an additional 680 shares in the last quarter. Raymond James Financial Services Advisors Inc. boosted its holdings in Amedisys by 9.2% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 2,397 shares of the health services provider’s stock worth $413,000 after buying an additional 202 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in Amedisys by 22.1% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 3,425 shares of the health services provider’s stock worth $590,000 after buying an additional 620 shares in the last quarter. HighTower Advisors LLC boosted its holdings in Amedisys by 40.4% during the first quarter. HighTower Advisors LLC now owns 7,619 shares of the health services provider’s stock worth $1,310,000 after buying an additional 2,193 shares in the last quarter. Finally, Citigroup Inc. boosted its holdings in Amedisys by 6.4% during the first quarter. Citigroup Inc. now owns 13,268 shares of the health services provider’s stock worth $2,287,000 after buying an additional 803 shares in the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have weighed in on AMED. Raymond James restated a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. StockNews.com began coverage on shares of Amedisys in a research report on Monday, April 8th. They set a “buy” rating for the company. Finally, Royal Bank of Canada upped their price objective on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, March 25th. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Amedisys presently has a consensus rating of “Hold” and an average price target of $97.50.

Amedisys Price Performance

Shares of NASDAQ AMED opened at $91.90 on Monday. The firm has a 50-day simple moving average of $93.05 and a 200-day simple moving average of $93.49. The stock has a market capitalization of $3.00 billion, a price-to-earnings ratio of -296.45, a price-to-earnings-growth ratio of 4.32 and a beta of 0.86. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.32. Amedisys, Inc. has a 52 week low of $73.10 and a 52 week high of $96.44.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, February 21st. The health services provider reported $0.94 EPS for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.10). The business had revenue of $570.79 million during the quarter, compared to analyst estimates of $566.85 million. Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. Amedisys’s quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter last year, the company earned $1.16 earnings per share. On average, equities analysts predict that Amedisys, Inc. will post 4.54 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.